GALWAY, Ireland and CHICAGO, March 30, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut™ transcatheter aortic valve...
Hence then, the article about medtronic evolut tavr system shows durable clinical outcomes and outstanding valve performance at five years in low risk aortic stenosis patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients )
Also on site :
- The Supreme Court Cast Its Lot With Trumpism. It Should Be Very Worried.
- My Wife Doesn’t Know I Watched Her Cheat On Me. My Reaction Might Shock Us Both.
- Eight fire crews tackling blaze at West Midlands Wetherspoon pub